Dicerna Pharmaceuticals, Inc.
THERAPEUTIC INHIBITION OF LACTATE DEHYDROGENASE AND AGENTS THEREFOR

Last updated:

Abstract:

This invention relates to compounds, compositions, and methods useful for reducing lactact dehydrogenase target RNA and protein levels via use of ds RNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.

Status:
Application
Type:

Utility

Filling date:

1 Jul 2020

Issue date:

17 Jun 2021